Screening for radiation sensitizers of Drosophila checkpoint mutants.
Screening for radiation sensitizers of Drosophila checkpoint mutants.
复制标题
筛选果蝇检查点突变体的辐射增敏剂。
DOI:
10.1007/978-1-61779-273-1_9
复制
发表时间:
2011
期刊:
影响因子:
--
通讯作者:
Su,TinTin
中科院分区:
文献类型:
--
作者:
Gladstone,Mara;Su,TinTin
Anti-cancer therapy is largely comprised of radiation, surgery, and chemotherapy treatments. Although a single mode of therapy can be effective in treating certain types of cancer, none presents a cure. Multi-modal therapy, the use of two or more agents in combination (e.g., radiation and chemotherapy together), shows potential for a more effective treatment of cancer. The challenge then is identifying effective therapy combinations. In this chapter, we describe the use of Drosophila as a whole animal in vivo model to screen for small molecules that effectively combine with ionizing radiation to kill checkpoint mutants preferentially over wild-type. The differential use of wild-type and checkpoint mutants has the potential to identify molecules that act in a genotype-specific manner to eradicate checkpoint mutant tissues when combined with radiation, while sparing wild-type tissues.